Pathways’ Picks October 7: Seen and Heard at The MedTech Conference

article image

In this week’s roundup we spotlight key insights on FDA, CMS, and global policies from this week’s MedTech Conference, and more to watch.

Key global policymakers convened, virtually, this week at AdvaMed’s MedTech Conference. In this week’s Pathways Picks: key takeaways by Market Pathways’ editors from the meeting, and also more to watch from around the global medtech policy arena.

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to Market Pathways:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to Market Pathways
Subscribe to ELITE Strategist

Become an ELITE Strategist and unlock access to both MedTech Strategist and MTS Market Pathways.

Subscribe to Elite


We're here to help! Please contact us at: